secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001753926-23-000985
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella Pharmaceuticals signs new lease for 3,275 sq ft office/manufacturing space
--------------------------------------------------------------------------------

- Lease with Bridgeway Development for ~3,275 sq ft at 7800 Susquehanna St, Pittsburgh, PA.
- Term runs Aug 1, 2023 to June 30, 2025, co-terminating with existing lease; five-year extension option.
- Annual base rent starts at ~$27,600 (year 1) and rises to ~$37,000 by final extension year.
- Premises will be used for office, manufacturing and assembly work in addition to current space.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623000985/0001753926-23-000985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392623000985/g083677_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-000985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer